Health Assessment & Technology Evaluation Market Size Analysis - Driven by digital therapeutics, PROMs, and data-driven decision-making.

Health Assessment and Technology Evaluation Market Size and Forecast

DataM Intelligence has published a new research report on "Health Assessment and Technology Evaluation Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Exclusive Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/health-assessment-and-technology-evaluation-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Recent Developments:
✅ October 2025: Health authorities across Europe expanded the use of real-world evidence (RWE) platforms in Health Assessment and Technology Evaluation to support faster reimbursement decisions for digital therapeutics and AI-enabled diagnostic tools. This shift improved post-market surveillance and reduced time-to-assessment for innovative health technologies.

✅ August 2025: Several Asia-Pacific countries introduced centralized Health Assessment and Technology Evaluation frameworks to standardize value-based pricing for medical devices and advanced therapies. The initiative strengthened transparency in cost-effectiveness analysis and supported sustainable healthcare spending.

✅ June 2025: Public healthcare systems increasingly integrated AI-driven economic modeling tools into Health Assessment and Technology Evaluation processes, enabling more accurate forecasting of long-term clinical outcomes and budget impact for novel biologics and personalized medicines.

✅ April 2025: The adoption of patient-reported outcome measures (PROMs) gained momentum within Health Assessment and Technology Evaluation, ensuring patient perspectives were systematically incorporated into technology appraisal and coverage decisions.

Mergers & Acquisitions:
✅ November 2025: A global health economics consultancy acquired a specialized real-world data analytics firm to strengthen its Health Assessment and Technology Evaluation capabilities for pharmaceutical and medtech clients.

✅ September 2025: A leading digital health assessment platform provider completed the acquisition of an AI-based evidence synthesis startup, enhancing automated literature review and comparative effectiveness analysis in Health Assessment and Technology Evaluation workflows.

✅ July 2025: A multinational healthcare advisory group acquired a regional HTA research organization, expanding its presence in emerging markets and supporting localized Health Assessment and Technology Evaluation submissions.

✅ May 2025: A life sciences technology company acquired a cloud-based cost-utility modeling solution provider, enabling faster and more scalable Health Assessment and Technology Evaluation for payers and regulatory bodies.

Key Players:

Philips Healthcare, GE Healthcare, IQVIA, IBM Watson Health, ICON Plc, Omron Healthcare, Orcha Health

Growth Forecast Projected:

The Global Health Assessment and Technology Evaluation Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Health Assessment and Technology Evaluation Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=health-assessment-and-technology-evaluation-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Key Segments:

By Technology Type
The market is segmented into Wearable Health Technology 30%, Telemedicine 25%, AI in Health Assessment 18%, Health Data Management 12%, Clinical Decision Support Systems (CDSS) 10%, and Genomics & Personalized Medicine 5%, with wearable health technology dominating due to rising adoption of smart devices for continuous health monitoring and real-time data tracking. Telemedicine holds a significant share driven by remote consultations and digital care delivery. AI-based health assessment tools are rapidly gaining traction for diagnostics and predictive analytics. Health data management and CDSS support clinical efficiency, while genomics and personalized medicine show emerging growth potential.

By Application
By application, the market includes Chronic Disease Management 35%, Preventive Healthcare 25%, Post-Operative Care 15%, Mental Health Assessments 15%, and Pediatrics & Geriatrics 10%, with chronic disease management leading due to the growing prevalence of diabetes, cardiovascular disorders, and respiratory diseases. Preventive healthcare is expanding with increased focus on early diagnosis and wellness monitoring. Post-operative care benefits from remote monitoring technologies. Mental health assessments show strong growth driven by digital mental health platforms. Pediatric and geriatric applications support steady adoption.

By End User
By end-user, the market is segmented into Hospitals 40%, Healthcare Providers 25%, Homecare Settings 20%, Diagnostic Laboratories 10%, and Research Institutes 5%, with hospitals dominating due to large patient volumes and high adoption of advanced digital health technologies. Healthcare providers increasingly adopt telehealth and AI tools for clinical decision-making. Homecare settings are rapidly growing with demand for remote monitoring and personalized care. Diagnostic laboratories and research institutes contribute to technology validation and innovation.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/health-assessment-and-technology-evaluation-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

FAQ

Q1: What is the current size of the Health Assessment and Technology Evaluation Market?

A: Health Assessment and Technology Evaluation Market reached US$ 760.22 million in 2024 and is expected to reach US$ 3304.84 million by 2033.

Q2: How rapidly will the Market expand?

A: The Health Assessment and Technology Evaluation market is projected to grow at a CAGR of 15.8% between 2025 and 2032.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.